LB Pharmaceuticals, Inc.

ACTIVE

575 Madison Ave 10TH FL, New York City, New York, United Stateswww.lbpharma.usHolding11–50 employeesEstablished: 2015-09-01

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2015

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

33.3%

Phase 2

33.3%

Phase 3

33.3%

Trial Status Distribution

Completed

50.0%

Recruiting

50.0%

Clinical Trials

Trials sponsored by this organization (6)

52-week Open Label Safety-Tolerability Study

Phase 3

Recruiting

interventional

Apr 2026900 participants

Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia

Phase 3

Recruiting

interventional

Mar 2026456 participants

Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.

Phase 2

Recruiting

interventional

Jan 2026320 participants

Randomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute Schizophrenia

Phase 2

Completed

interventional

Nov 2023359 participants

Receptor Occupancy of LB-102 Using Positron Emission Tomography (PET) in Healthy Volunteers

Phase 1

Completed

interventional

Jan 202116 participants

Safety and Tolerability of Single and Multiple Doses of LB-102 in Healthy Adults

Phase 1

Completed

interventional

Jan 202064 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations